title: Heart failure. Tardy but intact--publication of REVIVE trial results welcomed.
authors.forename: Megan
authors.initials: M
authors.lastname: Cully
mesh_terms: D022126:Access to Information; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006835:Hydrazones / Q000009:adverse effects / Q000627:therapeutic use*; D033181:Information Dissemination; D011724:Pyridazines / Q000009:adverse effects / Q000627:therapeutic use*; D012107:Research Design; D000077464:Simendan; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan